Profusa secures lumee™ oxygen platform distributor in spain

Berkeley, calif, july 31, 2025 (globe newswire) -- profusa, inc. (“profusa” or the “company”) (nasdaq: pfsa), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry, announces it has signed a letter of intent (loi) to enter into a distribution agreement in spain for its lumee oxygen platform. the spanish distributor, dismeval, s.l., specializes in the distribution of medical and surgical equipment throughout spain, including the canary and balearic islands. the distribution partner has an experienced and well trained team with in-depth knowledge of the medical device sector and hands-on expertise in supporting hospital-based clinical and technical operations.
PFSA Ratings Summary
PFSA Quant Ranking